L. Lachman

发表

H. Lieberman, L. Lachman, J. Schwartz, 1980 .

Interdependence of physiological surfactant and drug particle size on the dissolution behavior of water insoluble drugs.

L. Lachman, S. Lin, J. Menig, 1968, Journal of pharmaceutical sciences.

FACTORS INFLUENCING THE PROPERTIES OF FILMS USED FOR TABLET COATING. I. EFFECTS OF PLASTICIZERS ON THE WATER VAPOR TRANSMISSION OF CELLULOSE ACETATE PHTHALATE FILMS.

L. Lachman, A. Drubulis, 1964, Journal of pharmaceutical sciences.

Verapamil significantly increases serum concentrations of simvastatin but not pravastatin

Laishun Chen, L. Lachman, S. Donahue, 1999 .

Mibefradil significantly increases serum concentrations of atorvastatin but not pravastatin

Laishun Chen, L. Lachman, S. Donahue, 1999 .

Preliminary report on the comparative stability of certified colorants with lactose in aqueous solution.

L. Lachman, C. A. Brownley, 1963, Journal of pharmaceutical sciences.

ELECTROCAPILLARY CURVES OF EPHEDRINE AND PSEUDOEPHEDRINE.

J. W. Turner, L. Lachman, L. Malspeis, 1965, Journal of pharmaceutical sciences.

The theory and practice of industrial pharmacy

Joseph L. Kanig, Leon Lachman, Herbert A. Lieberman, 1970 .

BROWNING OF SPRAY-PROCESSED LACTOSE.

L. Lachman, C. A. Brownley, 1964, Journal of pharmaceutical sciences.

A study of the interaction between quaternary ammonium compounds and several certified dyes.

L. Lachman, R. Kuramoto, J. Cooper, 1958, Journal of the American Pharmaceutical Association. American Pharmaceutical Association.

Nonsolvolytic acetylation of homatropine by aspirin.

L. Lachman, J. Dudzinski, E. Shami, 1973, Journal of pharmaceutical sciences.

Lyophilization of pharmaceuticals. IV. Determination of eutectic temperatures of inorganic salts.

L Lachman, L. Lachman, P. De Luca, 1965, Journal of pharmaceutical sciences.

Lyophilization of pharmaceuticals. I. Effect of certain physical-chemical properties.

L. Lachman, P. Deluca, 1965, Journal of pharmaceutical sciences.

Inhibition of hydrolysis of esters in solution by formation of complexes. I. Stabilization of benzocaine with caffeine.

L. Lachman, T. Higuchi, 1955, Journal of the American Pharmaceutical Association. American Pharmaceutical Association.

Parenteral water-in-oil emulsions as adjuvants.

L. Lachman, J. Lazarus, 1967, Bulletin of the Parenteral Drug Association.

Use of 2-thiobarbituric acid-malonaldehyde reaction as a measure of antioxidant effectiveness in pharmaceutical oils.

L. Lachman, C. A. Brownley, 1965, Journal of pharmaceutical sciences.

Physical and chemical stability testing of tablet dosage forms.

L. Lachman, 1965, Journal of pharmaceutical sciences.

Analysis of homatropine methylbromide dosage forms.

L. Lachman, M. Rosen, S. Hanna, 1977, Journal of pharmaceutical sciences.

Twenty-four-hour intragastric pH: tolerance within 5 days of continuous ranitidine administration

L. Lachman, C. Howden, 2000, American Journal of Gastroenterology.

A study of the lyophilization of several pharmaceutical gums and suspending agents.

L. Lachman, L. Chavkin, 1957, Journal of the American Pharmaceutical Association. American Pharmaceutical Association.

Scientific EditionInhibition of Hydrolysis of Esters in Solution Formation of Complexes III.*: Stabilization of Tetracaine with Caffeine

L. Lachman, T. Higuchi, 1957 .

Inhibition of hydrolysis of esters in solution by formation of complexes. II. Stabilization of procaine with caffeine.

L. Lachman, T. Higuchi, L. J. Ravin, 1956, Journal of the American Pharmaceutical Association. American Pharmaceutical Association.

Comparative evaluation of tablet formulations prepared from conventionally-processed and spray-dried lactose.

L. Lachman, W. C. Gunsel, 1963, Journal of pharmaceutical sciences.

Pharmaceutical properties of drugs and dosage forms affecting physiological availability.

L. Lachman, W. Roemer, 1972, Journal of the American Pharmaceutical Association.

GLC determination of warfarin in human plasma.

P. Eisenberger, L. Lachman, M. Rosen, 1978, Journal of pharmaceutical sciences.

Color stability of tablet formulations. II. Influence of light intensity on the fading of several water-soluble dyes.

C. J. Swartz, L. Lachman, J. Cooper, 1960, Journal of the American Pharmaceutical Association. American Pharmaceutical Association.

Physical-chemical properties of substituted amides in aqueous solution and evaluation of their potential use as solubilizing agents.

L. Lachman, P. Deluca, H. Schroeder, 1973, Journal of pharmaceutical sciences.

Dissolution rate studies. IV. Solvent flow patterns in a column-type apparatus.

L. Lachman, J. Dudzinski, E. Shami, 1973, Journal of pharmaceutical sciences.

A study of the effect of certain pharmaceutical materials on color stability.

L. Lachman, R. Kuramoto, J. Cooper, 1958, Journal of the American Pharmaceutical Association. American Pharmaceutical Association.

Quantitative analysis of a multicomponent drug product using liquid chromatography.

L. Lachman, C. Hiskey, J. S. Mayell, 1974, Analytical chemistry.

A comprehensive pharmaceutical stability testing laboratory III. A light stability cabinet for evaluating the photosensitivity of pharmaceuticals.

C. J. Swartz, L. Lachman, J. Cooper, 1960, Journal of the American Pharmaceutical Association. American Pharmaceutical Association.

High-performance liquid chromatographic analysis of naloxone hydrochloride in injectable solutions

L. Lachman, S. Hanna, M. Insler, 1980 .

A Programmed Automated Film-Coating Process

L. Lachman, J. Cooper, 1963 .

Differential pulse polarographic determination of clorazepate monopotassium and dipotassium.

L. Lachman, S. Hanna, F. Diana, 1978, Journal of pharmaceutical sciences.

Inhibition of hydrolysis of esters in solution by formation of complexes. IV. Stabilization of benzocaine with 1-ethyltheobromine.

L. Lachman, T. Higuchi, D. Guttman, 1957, Journal of the American Pharmaceutical Association. American Pharmaceutical Association.

Stability of antibacterial preservatives in parenteral solutions II. Microbiological turbidimetric assay method for preservative content

L. Lachman, J. Weerts, Philip C. Eisman, 1963 .

Stability of antibacterial preservatives in parenteral solutions. IV. Contribution of rubber closure composition on preservative loss.

L. Lachman, T. Urbanyi, S. Weinstein, 1963, Journal of pharmaceutical sciences.

Color stability of tablet formulations. V. Effect of ultraviolet absorbers on the photostability of colored tablets.

C. J. Swartz, L. Lachman, J. Cooper, 1962, Journal of pharmaceutical sciences.

Color stability of tablet formulations. III. Comparative light fastness of several water-soluble dyes and their corresponding lakes.

C. J. Swartz, L. Lachman, J. Cooper, 1961, Journal of pharmaceutical sciences.

Stability of antibacterial preservatives in parenteral solutions. I. Factor influecing the loss of antimicrobial agents from solutions in rubber-stoppered containers.

L. Lachman, G. Hopkins, J. Cooper, 1963, Journal of pharmaceutical sciences.

The stability testing of pharmaceuticals.

L. Lachman, J. Cooper, 1959, Pharmaceutisch weekblad.

Reversible facial paralysis in sarcoidosis. Confirmation by serum angiotensin-converting enzyme assay.

L. Lachman, P. Hammerschlag, J. P. Cohen, 1983, Archives of otolaryngology.

A Kinetic Study of the Hydrolysis of Methyl DL-α-Phenyl-2-piperidylacetate *

L. Lachman, L. Malspeis, S. Siegel, 1959 .

Quality control in the pharmaceutical industry

L. Lachman, 1975 .

Simplified method for determining chemical stability of drug substances in pharmaceutical suspensions.

L. Lachman, J. Dudzinski, E. Shami, 1973, Journal of Pharmacy and Science.

Regulatory Inspection Trends and Findings of Bioanalytical Laboratories

Frank Chow, Martin Yau, Leon Lachman, 2013 .